Vorinostat (SAHA) and Breast Cancer: An Overview.

Wawruszak, Anna; Borkiewicz, Lidia; Okon, Estera; Kukula-Koch, Wirginia; Afshan, Syeda; Halasa, Marta

Wawruszak, Anna; Borkiewicz, Lidia; Okon, Estera; Kukula-Koch, Wirginia; Afshan, Syeda; Halasa, Marta.

Afiliación

Wawruszak A; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Borkiewicz L; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Okon E; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Kukula-Koch W; Department of Pharmacognosy, Medical University of Lublin, 20-093 Lublin, Poland.
Afshan S; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, 20521 Turku, Finland.
Halasa M; Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.

Cancers (Basel) ; 13(18)2021 Sep 19.

Article en En | MEDLINE | ID: mdl-34572928

Palabras clave

breast cancer; epigenetics; histone acetylation; histone deacetylase inhibitor (HDI); histone deacetylases (HDACs); suberoylanilide hydroxamic acid; targeted therapy; vorinostat (SAHA)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google